<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-11-06 23:50:11Vemurafenib Cancer Metastasis Protein kinase inhibitor Medicine Melanoma BRAF |
|
| First Page | Document Content | |
|---|---|---|
Date: 2014-11-06 23:50:11Vemurafenib Cancer Metastasis Protein kinase inhibitor Medicine Melanoma BRAF |
|
MSAC Application 1207: Consultation Decision Analytical Protocol (DAP) to guide the assessment of BRAF genetic testing in patients with melanoma for access to proposed PBS-funded GSK2118436 treatment January 2012